← Leaderboards
Yujun Zhang
Boston University Medical Campus
$1,153,985
Attributed
$1,153,985
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $298K · FY2005–08$500K$375K$250K$125K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$1,153,985 · 1
By mechanism
R01$1,153,985 · 1
Top collaborators
No co-investigators on record.
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Traci N. Bethea$690,532
- William W Cruikshank$2,220,243
- Gail E Sonenshein$16,606,360
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisBaseBinding (Molecular Function)Cancer CellCdkn1b GeneCell Cycle ArrestCell Cycle DeregulationCell Cycle RegulationCell LineCell ProliferationCellsChemical CarcinogenComplexCreb3 Protein, HumanCyclin-Dependent Kinase InhibitorCyclin-Dependent Kinase Inhibitor 1bCyclin-Dependent KinasesDeacetylaseDiagnosticDna BindingDna DamageDown-RegulationEctopic ExpressionAdaptor Signaling Protein
Grant awards (4)
Role of P80 pro-IL-16 in T Cell Malignancy$282,526
R01 · FY2008 · CA · contact PI
Role of P80 pro-IL-16 in T Cell Malignancy$282,526
R01 · FY2007 · CA · contact PI
Role of P80 pro-IL-16 in T Cell Malignancy$290,965
R01 · FY2006 · CA · contact PI
Role of P80 pro-IL-16 in T Cell Malignancy$297,968
R01 · FY2005 · CA